Phase II, Randomized, Placebo-controlled, 90-day Study of Emixustat HCL in Geographic Atrophy Associated with Dry Age-Related Macular Degeneration

PURPOSE: This study assessed the safety, tolerability, and pharmacodynamics of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD). METHODS: Subjects were randomly assigned to oral emi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Retina
Autors principals: Dugel, Pravin U., Novack, Roger L., Csaky, Karl G., Richmond, Preston P., Birch, David G., Kubota, Ryo
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452434/
https://ncbi.nlm.nih.gov/pubmed/25932553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000000606
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars